Transthyretin Amyloidosis (ATTR) Market Report

Global and Region Transthyretin Amyloidosis (ATTR) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：192
  • REPORT CODE：GMM952709
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Transthyretin Amyloidosis (ATTR) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Transthyretin Amyloidosis (ATTR)market, defines the market attractiveness level of Transthyretin Amyloidosis (ATTR) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Transthyretin Amyloidosis (ATTR) industry, describes the types of Transthyretin Amyloidosis (ATTR) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Transthyretin Amyloidosis (ATTR) market and the development prospects and opportunities of Transthyretin Amyloidosis (ATTR) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Transthyretin Amyloidosis (ATTR) market in Chapter 13.

    By Player:

    • Alnylam Pharmaceuticals

    • Corino Therapeutics

    • Proclara Bioscience

    • Arcturus Therapeutics

    • Pfizer

    • Ionis Pharmaceuticals

    By Type:

    • Hereditary ATTR (HATTR)

    • Wild-Type (WT) ATTR

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Transthyretin Amyloidosis (ATTR) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Transthyretin Amyloidosis (ATTR) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Transthyretin Amyloidosis (ATTR) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Transthyretin Amyloidosis (ATTR) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Transthyretin Amyloidosis (ATTR) Market Analysis and Outlook to 2022

    • 7.1 Global Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.2 United States Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.3 Europe Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.4 China Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.5 Japan Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.6 India Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    • 7.7 South Korea Transthyretin Amyloidosis (ATTR) Consumption (2017-2022)

    8 Region and Country-wise Transthyretin Amyloidosis (ATTR) Market Analysis and Outlook to 2028

    • 8.1 Global Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.2 United States Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.3 Europe Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.4 China Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.5 Japan Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.6 India Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    • 8.7 South Korea Transthyretin Amyloidosis (ATTR) Consumption Forecast (2022-2028)

    9 Global Transthyretin Amyloidosis (ATTR) Market Outlook by Types and Applications to 2022

    • 9.1 Global Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hereditary ATTR (HATTR) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Wild-Type (WT) ATTR Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    10 Global Transthyretin Amyloidosis (ATTR) Market Outlook by Types and Applications to 2028

    • 10.1 Global Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hereditary ATTR (HATTR) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Wild-Type (WT) ATTR Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Transthyretin Amyloidosis (ATTR) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Transthyretin Amyloidosis (ATTR) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Transthyretin Amyloidosis (ATTR) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Transthyretin Amyloidosis (ATTR) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Transthyretin Amyloidosis (ATTR) Market Competitive Analysis

    • 14.1 Alnylam Pharmaceuticals

      • 14.1.1 Alnylam Pharmaceuticals Company Details

      • 14.1.2 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Service

    • 14.2 Corino Therapeutics

      • 14.2.1 Corino Therapeutics Company Details

      • 14.2.2 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product and Service

    • 14.3 Proclara Bioscience

      • 14.3.1 Proclara Bioscience Company Details

      • 14.3.2 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product and Service

    • 14.4 Arcturus Therapeutics

      • 14.4.1 Arcturus Therapeutics Company Details

      • 14.4.2 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Transthyretin Amyloidosis (ATTR) Product and Service

    • 14.6 Ionis Pharmaceuticals

      • 14.6.1 Ionis Pharmaceuticals Company Details

      • 14.6.2 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Transthyretin Amyloidosis (ATTR)

    • Figure Transthyretin Amyloidosis (ATTR) Picture

    • Table Global Transthyretin Amyloidosis (ATTR) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transthyretin Amyloidosis (ATTR) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Transthyretin Amyloidosis (ATTR) Consumption by Country (2017-2022)

    • Figure United States Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Table Europe Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Figure China Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Figure Japan Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Figure India Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transthyretin Amyloidosis (ATTR) Consumption and Growth Rate (2017-2022)

    • Figure Global Transthyretin Amyloidosis (ATTR) Consumption Forecast by Country (2022-2028)

    • Figure United States Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transthyretin Amyloidosis (ATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hereditary ATTR (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure Global Wild-Type (WT) ATTR Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Hereditary ATTR (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wild-Type (WT) ATTR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Transthyretin Amyloidosis (ATTR) Export by Region (Top 5 Countries) (2017-2028)

    • Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Service

    • Table Corino Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product and Service

    • Table Proclara Bioscience (Foundation Year, Company Profile and etc.)

    • Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product and Service

    • Table Arcturus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Transthyretin Amyloidosis (ATTR) Product and Service

    • Table Ionis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US